Abexinostat (Compound)

Synonyms:ABEXINOSTAT, 783355-60-2, PCI-24781, PCI 24781, CRA-024781, CRA 024781, CRA-02478, PCI24781, CRA 24781, Abexinostat [USAN], 3-((dimethylamino)methyl)-N-(2-(4-(hydroxycarbamoyl)phenoxy)ethyl)benzofuran-2-carboxamide, Abexinostat (PCI-24781), PCI-24781 (Abexinostat), S78454, IYO470654U, PZP115891, 3-((Dimethylamino)methyl)-N-(2-(4-(hydroxycarbamoyl)-phenoxy)ethyl)benzofuran-2-carboxamide, Abexinostat (USAN), PZP-115891, 3-(dimethylaminomethyl)-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide, 3-[(dimethylamino)methyl]-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide, 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofuran-2-carboxamide, S-78454, 3-[(Dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-2-benzofurancarboxamide, 2-Benzofurancarboxamide, 3-((dimethylamino)methyl)-N-(2-(4-((hydroxyamino)carbonyl)phenoxy)ethyl)-, Abexinostat [USAN:INN], UNII-IYO470654U, PCI-24781 (CRA-024781), 3-((DIMETHYLAMINO)METHYL)-N-(2-(4-(HYDROXYCARBAMOYL)PHENOXY)ETHYL)-1-BENZOFURAN-2-CARBOXAMIDE, CRA024781, ABEXINOSTAT [INN], ABEXINOSTAT [WHO-DD], MLS006011097, SCHEMBL444280, GTPL8366, CHEMBL2103863, BDBM24622, CHEBI:92223, DTXSID30229005, BCPP000128, HMS3654A19, EX-A2123, CRA-24781, FD5037, MFCD10565969, NSC764136, AKOS025149423, BCP9001054, CCG-264814, CS-0478, DB12565, NSC-764136, SB16670, NCGC00346486-01, NCGC00346486-05, AC-26866, BS-18153, HY-10990, SMR004702885, DB-075461, PCI-24781,CRA-024781, FT-0673532, SW218266-2, EC-000.2348, D10060, EN300-204651, J-511438, Q4667249, BRD-K12867552-001-01-3

Pubchem:PUBCHEM:11749858

Id:5e3bde7f-171a-57c5-864b-ebf665058468

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Abexinostat's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Abexinostat.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Abexinostat.

Results found

Linked to

	Label	Description
	BRD-K12867552-001-04-7 Substance (Entity type)	A Substance
	abexinostat (51417e52-26ba-484f-a9df-200fde25f190) Collection (Entity type)	Metadatata for abexinostat
	Abexinostat negatively regulates KRT13 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Abexinostat positively regulates CYFIP2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Abexinostat negatively regulates HMGB2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Abexinostat negatively regulates TLCD3A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	midazolam in similarity relationship with Abexinostat Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Abexinostat bioactivity Histone deacetylase 6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Abexinostat bioactivity Histone deacetylase 1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Pracinostat in similarity relationship with Abexinostat Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS